B. Braun Compounding will supply a wide range of aseptically prepared products.
Chemotherapy - Both patient specific and batch chemotherapy
Parenteral Nutrition - Either additions to our range of convenience 2-chambered and 3-chambered bags or compounded PN for both adult and paediatric/neonatal formulations
CIVAS - A range of products to support hospitals in implementing the NPSA Alert 20
Pain Management - A range of elastomeric infusion devices filled with various local anaesthetic agents to provide pain control for both nerve block and wound infiltration pain therapy
B. Braun Compounding is situated in the heart of the UK at our Headquarters in Sheffield.
This makes our service ideally placed to supply aseptically prepared products easily and efficiently throughout the UK.
All raw materials are warehoused at this site ensuring a fast, effìcient and reliable supply to our customers.
B. Braun always use stringent quality management systems to ensure exceptional quality of all products we supply to our customers.
B. Braun Compounding will be no exception. All our aseptically prepared products will be made in a facility operating to current GMP standards which will guarantee high quality products are produced and supplied every time.
B. Braun Compounding will be fully licensed by the MHRA for the supply of aseptically compounded specials and we welcome customers to visit and audit our facility and processes.
B. Braun has always been committed to increasing patient safety by innovation throughout our product portfolio.
With innovative labelling and packaging solutions, B. Braun Compounding will incorporate the recommendations of the NPSA Alert 20 guidance into our compounding service.
B. Braun has already hosted and will continue to conduct NPSA seminars throughout the UK, to ensure the latest guidance and recommendations are implemented into our compounding service.